Section Navigation
Section Navigation
- Module 5 Overview
Prevention of HIV - 0%Lesson 1
Preventing Perinatal HIV TransmissionActivities- 0%Lesson 2
Preventing HIV Transmission in Persons with HIVActivities- 0%Lesson 3
Occupational Postexposure ProphylaxisLesson 4. Nonoccupational Postexposure Prophylaxis
Learning Objective Performance Indicators
- Describe indications for the use of HIV nonoccupational postexposure prophylaxis (PEP)
- Summarize appropriate antiretroviral therapy regimens and duration of therapy for HIV nonoccupational PEP
- List recommended clinical and laboratory monitoring following nonoccupational exposure to HIV
- Identify appropriate candidates for transition from HIV nonoccupational PEP to HIV preexposure prophylaxis (PrEP)
- Discuss indications for obtaining expert consultation for HIV nonoccupational PEP
About this Lesson
Learning Objective Performance Indicators
- Describe indications for the use of HIV nonoccupational postexposure prophylaxis (PEP)
- Summarize appropriate antiretroviral therapy regimens and duration of therapy for HIV nonoccupational PEP
- List recommended clinical and laboratory monitoring following nonoccupational exposure to HIV
- Identify appropriate candidates for transition from HIV nonoccupational PEP to HIV preexposure prophylaxis (PrEP)
- Discuss indications for obtaining expert consultation for HIV nonoccupational PEP
Activities in this Lesson
- Quick ReferenceNonoccupational Postexposure Prophylaxis Core Concepts
- Introduction and Background
- Rationale for Providing HIV Nonoccupational PEP
- Evaluation for HIV Nonoccupational PEP
- Indications for Initiating HIV Nonoccupational PEP
- Recommended Regimens for HIV Nonoccupational PEP
- Expert Consultation for HIV Nonoccupational PEP
- Baseline and Follow-Up Laboratory Testing
- HIV Nonoccupational PEP After Sexual Assault
- Initial Medication Prescription and Follow-up after Evaluation
- Transitioning from HIV Nonoccupational PEP to HIV PrEP
- Nonoccupational PEP for Infectious Pathogens Other Than HIV
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Health Resources and Services Administration (HRSA)
Created at
University of Washington
An AETC Program
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE approved byOregon Nurses Association
Copyright © 2025 National HIV Curriculum
The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,172,994. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-d52d2330-2025-09-05-201745
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant